966 related articles for article (PubMed ID: 33838559)
21. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
[TBL] [Abstract][Full Text] [Related]
22. New 1,2,4-oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity.
Frejat FOA; Cao Y; Wang L; Zhai H; Abdelazeem AH; Gomaa HAM; Youssif BGM; Wu C
Arch Pharm (Weinheim); 2022 Jul; 355(7):e2100516. PubMed ID: 35363388
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.
Haiba NS; Khalil HH; Moniem MA; El-Wakil MH; Bekhit AA; Khattab SN
Bioorg Chem; 2019 Aug; 89():103013. PubMed ID: 31174040
[TBL] [Abstract][Full Text] [Related]
24. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
25. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
26. Targeted potent antimicrobial benzochromene-based analogues: Synthesis, computational studies, and inhibitory effect against 14α-Demethylase and DNA Gyrase.
Fouda AM; Hassan AH; Eliwa EM; Ahmed HEA; Al-Dies AM; Omar AM; Nassar HS; Halawa AH; Aljuhani N; El-Agrody AM
Bioorg Chem; 2020 Dec; 105():104387. PubMed ID: 33130344
[TBL] [Abstract][Full Text] [Related]
27. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
Ponnusamy T; Alagumuthu M; Thamaraiselvi S
Bioorg Med Chem; 2018 Jul; 26(12):3438-3452. PubMed ID: 29803359
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids.
Rizk OH; Bekhit MG; Hazzaa AAB; El-Khawass EM; Abdelwahab IA
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900086. PubMed ID: 31389630
[TBL] [Abstract][Full Text] [Related]
29. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor.
Salem MA; Ragab A; Askar AA; El-Khalafawy A; Makhlouf AH
Eur J Med Chem; 2020 Feb; 188():111977. PubMed ID: 31927313
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.
Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824
[TBL] [Abstract][Full Text] [Related]
31. Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing.
Metelytsia L; Hodyna D; Dobrodub I; Semenyuta I; Zavhorodnii M; Blagodatny V; Kovalishyn V; Brazhko O
Comput Biol Chem; 2020 Apr; 85():107224. PubMed ID: 32018168
[TBL] [Abstract][Full Text] [Related]
32. New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus.
Samir M; Ramadan M; Abdelrahman MH; Elbastawesy MAI; Halby HM; Abdel-Aziz M; Abuo-Rahma GEA
Bioorg Med Chem; 2022 Nov; 73():117004. PubMed ID: 36148773
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial and molecular docking studies of newly synthesized nucleosides and Schiff bases derived from sulfadimidines.
Amer HH; Eldrehmy EH; Abdel-Hafez SM; Alghamdi YS; Hassan MY; Alotaibi SH
Sci Rep; 2021 Sep; 11(1):17953. PubMed ID: 34504157
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.
Tomašič T; Barančoková M; Zidar N; Ilaš J; Tammela P; Kikelj D
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29239018
[TBL] [Abstract][Full Text] [Related]
35. Development and radiosterilization of new hydrazono-quinoline hybrids as DNA gyrase and topoisomerase IV inhibitors: Antimicrobial and hemolytic activities against uropathogenic isolates with molecular docking study.
Ammar YA; Micky JA; Aboul-Magd DS; Abd El-Hafez SMA; Hessein SA; Ali AM; Ragab A
Chem Biol Drug Des; 2023 Feb; 101(2):245-270. PubMed ID: 36305722
[TBL] [Abstract][Full Text] [Related]
36. Novel terpyridines as
Mohamed MA; Abouzied AS; Reyad A; Sayed Abdelsalam Zaki ME; Abdelgawad FE; Al-Humaidi JY; Gomha SM
Future Med Chem; 2024 Feb; 16(3):205-220. PubMed ID: 38230640
[No Abstract] [Full Text] [Related]
37. Antibacterial Evaluation, In Silico Characters and Molecular Docking of Schiff Bases Derived from 5-aminopyrazoles.
Hassan AS; Askar AA; Nossier ES; Naglah AM; Moustafa GO; Al-Omar MA
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466322
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase/topoisomerase IV inhibition.
Ismail MMF; Abdulwahab HG; Nossier ES; El Menofy NG; Abdelkhalek BA
Bioorg Chem; 2020 Jan; 94():103437. PubMed ID: 31812260
[TBL] [Abstract][Full Text] [Related]
39. Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity.
Fois B; Skok Ž; Tomašič T; Ilaš J; Zidar N; Zega A; Peterlin Mašič L; Szili P; Draskovits G; Nyerges Á; Pál C; Kikelj D
ChemMedChem; 2020 Feb; 15(3):265-269. PubMed ID: 31721445
[TBL] [Abstract][Full Text] [Related]
40. N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Xue W; Li X; Ma G; Zhang H; Chen Y; Kirchmair J; Xia J; Wu S
Eur J Med Chem; 2020 Feb; 188():112022. PubMed ID: 31901744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
